High-Powered Alliance to Tackle Prescription-Drug Abuse

The new group brings industry organizations together for the first time to address the epidemic.

A picture taken on September 13, 2012 in Paris shows pills and medicines. AFP/MIGUEL MEDINA (Photo credit should read MIGUEL MEDINA/AFP/GettyImages)
National Journal
Sophie Novack
Add to Briefcase
Sophie Novack
Feb. 28, 2014, 10:07 a.m.

Some of the biggest play­ers in the phar­ma­ceut­ic­al sup­ply chain have teamed up to find solu­tions to the grow­ing prob­lem of pre­scrip­tion-drug ab­use.

The Al­li­ance to Pre­vent the Ab­use of Medi­cines is com­posed of the Amer­ic­an Med­ic­al As­so­ci­ation, CVS Care­mark, Teva Phar­ma­ceut­ic­als, Car­din­al Health, the Health­care Dis­tri­bu­tion Man­age­ment As­so­ci­ation, and Prime Thera­peut­ics.

The group touts mem­ber­ship in­volve­ment across the sup­ply chain — from man­u­fac­turer to dis­trib­ut­or to phar­macy to phys­i­cian — as key to the suc­cess of its mis­sion.

“In or­der to truly move the needle on an is­sue as com­plex and massive as pre­scrip­tion-drug ab­use, there has to be co­oper­a­tion and in­put along the en­tire phar­ma­ceut­ic­al sup­ply chain,” Al­li­ance spokes­per­son Dani­elle Ha­gen wrote in an email. “The al­li­ance has come to­geth­er to provide just that. Each mem­ber or­gan­iz­a­tion re­cog­nizes the need for a com­pre­hens­ive pub­lic health ap­proach to pre­scrip­tion drug ab­use, and each comes to the table with valu­able ex­pert­ise.”

Pre­scrip­tion-drug ab­use has been clas­si­fied as an epi­dem­ic by the Cen­ters for Dis­ease Con­trol and Pre­ven­tion. Ac­cord­ing to data from the Na­tion­al Sur­vey on Drug Use and Health, ini­ti­ation rates for non­med­ic­al pain re­liev­er use are second only to marijuana, with 2 mil­lion or more new users every year since 2002 — 500,000 of whom have nev­er used an­oth­er il­li­cit drug.

Pre­scrip­tion-drug ab­use is dif­fi­cult to tackle be­cause it in­volves many dif­fer­ent play­ers and mov­ing parts along the drug sup­ply chain. Thus far, piece­meal le­gis­la­tion that ad­dresses parts of the prob­lem has largely been in­ef­fect­ive.

The Al­li­ance hopes to take a broad­er look at the pre­scrip­tion-drug mar­ket and work with le­gis­lat­ors on Cap­it­ol Hill to find more com­pre­hens­ive solu­tions.

The group plans to main­tain a na­tion­al policy per­spect­ive, while also work­ing with state law­makers. The first fo­cus is on im­prov­ing the Pre­scrip­tion Drug Mon­it­or­ing Pro­gram, which var­ies a great deal from state to state. The Al­li­ance sent a let­ter to the Na­tion­al Gov­ernors As­so­ci­ation that was shared at the winter meet­ing last week, call­ing for a more ro­bust and in­ter­op­er­able sys­tem of PDMPs. The group re­ceived a pos­it­ive re­sponse from those gov­ernors present, ac­cord­ing to a spokes­per­son.

The Al­li­ance is still work­ing through solu­tions on what will likely be a long-term ef­fort, and de­clined to give fur­ther de­tails on oth­er pos­sible pro­pos­als.

What We're Following See More »
UNANIMOUS DECISION
SCOTUS Rules Against Venue Shopping in Patent Cases
53 minutes ago
THE DETAILS

Writing for an 8-0 Supreme Court on Monday, Justice Clarence Thomas wrote that patent lawsuits "must be brought in the state where the defendant company is incorporated. ... The ruling likely spells an end to the near-monopoly the federal court in the Eastern District of Texas holds in handling patent cases. Plaintiffs for decades have filed suits in that pro-plaintiff district based on a broader interpretation of venue that made suits possible almost anywhere."

Source:
BASED ON FIFTH AMENDMENT
Flynn To Refuse To Cooperate With Subpoena
1 hours ago
BREAKING

Former National Security Adviser to President Donald Trump Michael Flynn will refuse to cooperate with a subpoena from the Senate Intelligence Committee. "Flynn will invoke his Fifth Amendment protection against self-incrimination." Flynn was unlikely to turn over any documents without being granted immunity, as he "has previously sought immunity from 'unfair prosecution.'"

Source:
UNCERTAINTY THROUGH AUGUST
White House To Request Second 90-Day Delay In Obamacare Subsidy Case
2 hours ago
BREAKING

The Trump administration plans to ask a federal court Monday for a second 90-day delay in a lawsuit over Obamacare subsidies. The lawsuit, House vs. Price, revolves around the Obamacare co-payment program, which pays health insurers who partake in the Obamacare exchanges to ensure that people without means can gain coverage without having to pay unaffordable co-payments.

ISOLATION VS. OPENNESS
Trump Puts Rouhani in a Tough Spot
2 hours ago
THE DETAILS

"On Sunday, U.S. President Donald Trump called on the world to isolate Iran," to the delight of his Sunni hosts, Saudi Arabia. Meanwhile, however, on Saturday, "Iranians poured into the streets by the hundreds of thousands to celebrate the re-election of President Hassan Rouhani, whose message of opening up to the West helped him to trounce a hard-line challenger."

Source:
TILLERSON SAYS IT’S PART OF JERUSALEM
Trump Becomes First President To Visit Western Wall
2 hours ago
BREAKING
×
×

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.

Login